MedTrace Logo

The Effect of Sodium Bicarbonate (Nephrotrans®) on Calcification Propensity of Serum in Kidney Transplant Recipients

NCT03301558 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2026-04-27

No results posted yet for this study

Summary

This is a single-center, prospective, open-label, randomized, cross-over study.

Conditions

  • Kidney Transplant; Complications

Interventions

DRUG

Low dose sodium bicarbonate

1500 mg sodium bicarbonate

DRUG

High dose sodium bicarbonate

3000 mg sodium bicarbonate

Sponsors & Collaborators

  • Medice Arzneimittel Pütter GmbH & Co KG

    collaborator INDUSTRY

  • Prim. Priv. Doz. Dr. Daniel Cejka

    lead OTHER

Principal Investigators

  • Daniela Cejka, MD · Head of Nephrology

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-31
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03301558 on ClinicalTrials.gov